secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001214659-23-006006
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro announces 2023 annual meeting voting results; all proposals pass
-------------------------------------------------------------------------------

- Elected directors: Horne, Jackman, Nisser, Gustafson, McGrath, Woo, Oram; each received >46.6M votes for.
- Advisory vote on executive compensation approved: 48.4M for, 1.3M against.
- Say-on-frequency set to every 3 years (39.7M votes for 3 years); next advisory vote in 2026.
- Ratification of Baker Tilly US, LLP as auditor for FY ending April 30, 2023 approved: 49.6M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923006006/0001214659-23-006006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923006006/o4262338k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-006006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer